GetTopicDetailResponse(id=013fe83352, topicName=gantenerumab, introduction=gantenerumab, content=null, image=null, comments=1, allHits=1163, url=https://h5.medsci.cn/topic?id=7833, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=99602, tagList=[TagDto(tagId=99602, tagName=gantenerumab)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2257430, encodeId=adca225e430a2, content=<a href='/topic/show?id=3cbe9e7892e' target=_blank style='color:#2F92EE;'>#阿爾茨海默病#</a> <a href='/topic/show?id=013fe83352' target=_blank style='color:#2F92EE;'>#gantenerumab#</a>, objectTitle=癡呆風(fēng)險(xiǎn)降低約50%！《柳葉刀》子刊：早期并長期靶向治療，或能延緩發(fā)病, objectType=article, longId=868532, objectId=03168685329f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240714/1720959810929_5579292.jpg, objectUrl=/article/show_article.do?id=03168685329f, replyNumber=0, likeNumber=37, createdTime=2025-03-23, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=03168685329f, moduleTitle=癡呆風(fēng)險(xiǎn)降低約50%！《柳葉刀》子刊：早期并長期靶向治療，或能延緩發(fā)病, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=03168685329f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2118654, encodeId=c51a2118654b5, content=52名攜帶突變的參與者被分配接受<a href='/topic/show?id=013fe83352' target=_blank style='color:#2F92EE;'>#gantenerumab#</a>治療，52名參與者接受<a href='/topic/show?id=536016532df' target=_blank style='color:#2F92EE;'>#Solanezumab#</a>治療，另外40名參與者接受安慰劑治療。兩種藥物都涉及其Aβ靶點(diǎn)，但與對照組相比，都沒有顯示出對認(rèn)知能力的有益影響。<a href='/topic/show?id=e3009e77006' target=_blank style='color:#2F92EE;'>#阿爾茲海默癥#</a>，太難了，又倒下兩個(gè), objectTitle=Nat Med：遺憾，Gantenerumab或Solanezumab對于顯性遺傳阿爾茲海默癥無效, objectType=article, longId=213067, objectId=919921306ed9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/142214-forgetting.jpg, objectUrl=/article/show_article.do?id=919921306ed9, replyNumber=0, likeNumber=168, createdTime=2023-03-10, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=919921306ed9, moduleTitle=Nat Med：遺憾，Gantenerumab或Solanezumab對于顯性遺傳阿爾茲海默癥無效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=919921306ed9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
